Table 2.
Completed HIV-1 vaccine studies according to the clinicaltrials.gov website.
| Title | Conditions | ID |
|---|---|---|
| HIV Testing & Womens Attitudes on HIV Vaccine Trials | HIV-1 | NCT00771537 |
| Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV Infected Persons | HIV-1 | NCT01218113 |
| Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial | HIV-1 | NCT00337181 |
| Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-infected Subjects | HIV-1 | NCT01610427 |
| HIV Vaccine Trial in Thai Adults | HIV-1 | NCT00223080 |
| A Safety and Immune Response Study of 2 Experimental HIV Vaccines | HIV-1 | NCT02404311 |
| Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine | HIV-1 | NCT03284710 |
| The Safety and Immunogenicity of a Potential HIV Vaccine | HIV-1 | NCT01966900 |
| Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027) | HIV-1 | NCT00350623 |
| Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023) | HIV-1 | NCT00095576 |
| Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732,461 in Healthy HIV Seronegative Volunteers | HIV-1 | NCT00434512 |
| Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths | Hepatitis B | NCT00107042 |
| A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects | HIV-1 | NCT00833781 |
| HIV-1 Peptide Immunization of Individuals in West Africa to Prevent Disease | HIV-1 | NCT01141205 |
| Therapeutic Vaccine for HIV | HIV-1 | NCT01859325 |
| Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women | Pneumococcal | NCT02717494 |
| H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients | HIV-1 | NCT01111162 |
| Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women | HIV-1 | NCT00710593 |
| Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men | HIV-1 | NCT00865566 |
| A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016) | HIV-1 | NCT00849680 |
| Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals | HIV-1 | NCT01262846 |
| Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults | Hepatitis B | NCT03316807 |
| Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects | HIV-1 | NCT00706550 |
| Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) | HIV-1 | NCT03368053 |
| Early Versus Delayed BCG Vaccination of HIV-exposed Infants | HIV-1 | NCT00712530 |
| Combination Vaccination Before HIV Treatment Interruption | HIV-1 | NCT02062580 |
| Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 | HIV-1 | NCT02852005 |
| Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females | HPV-1 | NCT01031069 |
| Immunogenicity of Fluzone HD, A High Dose Influenza Vaccine, In Children With Cancer or HIV | HIV-1 | NCT01205581 |
| Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults | HIV-1 | NCT02474901 |
| Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy | Herpes Zoster | NCT00851786 |
| Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth | H1N1 Influenza | NCT00992836 |
| Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers | Rotavirus | NCT00880698 |
| Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are € to Pneumococcal Vaccine | Pneumococcal | NCT00962780 |
| Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women | H1N1 Influenza | NCT00992017 |
| Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection | HIV-1 | NCT01009762 |
| Safety and Immunogenicity of IMVAMUNE (MVA-BN) Smallpox Vaccine in HIV Infected Patients | HIV-1 | NCT00316589 |
| Autologous Dendritic Cell Vaccine in HIV1 Infection | HIV-1 | NCT00510497 |
| Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women | HIV-1 | NCT01461096 |
| Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women | HPV-1 | NCT00604175 |
| Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth | Hepatitis B | NCT00106964 |
| Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children | HPV | NCT00339040 |
| Safety of and Immune Response to a Meningitis Vaccine in HIV Infected Children and Youth | Meningitis | NCT00459316 |
| Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir | HIV-I | NCT02092116 |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals’ HPV Vaccine 580,299 (Cervarix) in HIV Infected Females | HPV | NCT00586339 |
| The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata | HPV | NCT00941889 |
| Immune Response After Booster Vaccination in HIV-Infected Patients Who Received Rabies Primary Vaccination | Rabies | NCT01286493 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults. | Tuberculosis | NCT00707967 |
| Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS | Pneumococcal | NCT00963235 |
| Study to Evaluate GSK Biologicals’ Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus HIV Infected Subjects | Herpes Zoster | NCT01165203 |
| Vaccine Therapy in Preventing HPV in HIV-Positive Women in India | HPV | NCT00667563 |
| Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose | HIV-1 | NCT00972725 |
| Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults | HIV-1 | NCT02915016 |
| Safety and Immunogenicity of GSK Biologicals’ Investigational Malaria Vaccine in HIV Infected Infants and Children | Malaria | NCT01148459 |
| Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings | Streptococcal | NCT01412801 |
| Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | HPV | NCT01209325 |
| Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. | Pneumococcal | NCT00829010 |
| Intradermal Versus Intramuscular Polio Vaccine Booster in HIV Infected Subjects | Polio | NCT01686503 |
| Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection | HPV | NCT00513526 |
| MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) | Hepatitis C | NCT00857311 |